Cell Therapy

Type: Keyphrase
Name: Cell Therapy
First reported Sep 17 2014 - Updated Sep 17 2014 - 1 reports

Regenerative Medicine Market (Bone and Joint) (By Technology - Stem Cell Therapy, Biomaterial and Tissue Engineering; By Applications - Bone Graft Substitutes, Osteoarticular Diseases, Allogeneic Products, Autogenic Products and Others) - Global Ind

LONDON, Sept. 17, 2014 /PRNewswire/ -- U.S. National Institute of Health stated that regenerative medicine is the process of creating functional tissue to repair and replace tissue or organ which has lost their function due to damage, congenital defects, ... [Published PR Newswire: General Business - Sep 17 2014]
First reported Sep 17 2014 - Updated Sep 17 2014 - 1 reports

World’s First for AMD Stem Cell Therapy

(Optometry Today) – A patient in Japan has become the first person to be treated with a stem cell treatment for age –related macular degeneration (AMD). In a world first, researchers at the RIKEN Centre for Developmental Biology (CDB), in ...Related Biotechnology, ... [Published BioPortfolio - Sep 17 2014]
First reported Sep 17 2014 - Updated Sep 17 2014 - 1 reports

Business leader appointed to review Cooperative Research Centres

Prominent lawyer and innovation expert David Miles AM has been appointed to lead the review of the Australian Government’s Cooperative Research Centres (CRC) Programme.Minister for Industry Ian Macfarlane said Mr Miles, the former Chair of Innovation ... [Published Australian Government - Sep 17 2014]
First reported Sep 16 2014 - Updated Sep 16 2014 - 1 reports

New method puts Anya’s leukemia in remission

Anya Martinez is on her way home with good news.The Ancaster girl undergoing experimental leukemia treatment in Philadelphia has been told her cancer has gone into remission.Anya, 6, had a bone marrow and spinal tap last week to determine the success ... [Published Hamilton Spectator - Sep 16 2014]
First reported Sep 16 2014 - Updated Sep 16 2014 - 1 reports

Northwest Bio's Cell Therapy Named 'Promising Innovative Medicine'

An innovative cell therapy for cancer has become the first designated "promising" as part of a scheme to get medicines to patients quicker. Related Biotechnology, Pharmaceutical and Healthcare News The medicine, named DCVax-L, has been developed by ... [Published BioPortfolio - Sep 16 2014]
First reported Sep 12 2014 - Updated Sep 13 2014 - 2 reports

Woman Receives First Stem Cell Therapy Using Her Own Skin Cells

A Japanese woman is the first to receive retinal cells made from her own skin cellsResearchers at the RIKEN Center for Developmental Biology in Japan surgically transplanted a sheet of retinal pigment cells into the eye of a 70-year old women on Frid ... [Published Time - Sep 12 2014]
First reported Sep 13 2014 - Updated Sep 13 2014 - 1 reports

Clinical trials start for treating advanced solid tumours with vaccines made from patient’s own cells

Specialists at the Department of Paediatrics and the Area of Cell Therapy at the University Hospital of Navarra have initiated new treatment with a vaccine made from cells of the patient’s own immune system (dendritic cells).These cell units are prepared ... [Published Health Canal - Sep 13 2014]
First reported Sep 12 2014 - Updated Sep 12 2014 - 1 reports

New Nanomedicine Provides Faster, More Efficient Stem Cell Therapy

North Carolina State University - A targeted nanoparticle created by researchers at North Carolina State University and the Cedars-Sinai Heart Institute may help heart attack patients regenerate healthy heart tissue without using donated or processed ... [Published Crawford Financial Planning - Sep 12 2014]
First reported Sep 12 2014 - Updated Sep 12 2014 - 1 reports

OVATION Hair® Surpasses 1 Million Order Milestone

Ovation Hair Ships Millionth Order and Celebrates Ovation Hair has been helping clients achieve healthy hair since 2007. Their flagship product, Ovation Cell Therapy, is proven to deliver thicker, stronger, longer hair. The entire line of Ovation Hair ... [Published PRWeb - Sep 12 2014]
First reported Sep 08 2014 - Updated Sep 09 2014 - 2 reports

More than 6,000 Patients Benefitted in Cuba from Stem Cell Therapy

Havana, September 8 (RHC) – A total of 6,195 patients were treated in Cuba with stem cells in the first half of 2014, while the medical procedure has been expanded to 14 provinces since it was first administered here in 2004.Doctor Porfirio Hernandez, ... [Published Radio Habana Cuba - Sep 08 2014]
First reported Aug 29 2014 - Updated Aug 29 2014 - 2 reports

Eversheds advises Cell Therapy Catapult on cell therapy joint venture

Law firm Eversheds has advised the Cell Therapy Catapult on an innovative partnership with UCL Business (UCLB) and Imperial Innovations for the advancement of a novel cell therapy approach to treat acute myeloid leukaemia.The joint venture, named Catapult ... [Published Noodls - Aug 29 2014]
First reported Aug 26 2014 - Updated Aug 26 2014 - 4 reports

Irvine Scientific Introduces Serum-Free Differentiation Media to Its Cell Therapy Product Line

SANTA ANA, Calif.--(EON: Enhanced Online News)--Irvine Scientific introduces serum-free differentiation media to PRIME-XV® cell therapy product line. ... [Published EON Science - Aug 26 2014]
Entities: Cell Therapy

Quotes

He described the treatment as "harnessing the power of the immune system to go after cancer in an extremely targeted way."
"We are happy to be called upon by the media and the investment community to discuss the advancements being made in regenerative medicine. Cell therapy products like RepliCel's represent a new way to repair and rejuvenate patients effected by aging and injury. In the months ahead, RepliCel will be fully engaged with three clinical trials targeting chronic tendinosis, sun damaged and aging skin and hair loss in addition to a parallel trial anticipated to launch by its partner, Shiseido . Data from these trials will help pave the way for other RepliCel products targeting diseases and conditions associated with a deficit of healthy functioning cells" commented David Hall , CEO of RepliCel
"FIG. 14 demonstrates that SP based hydrogels functionalized with laminin (middle) or collagen IV (right) improve the viability of the Insulinoma cell line in vitro over nonfunctionalized SP based hydrogels (left). Cells stained red with propidium iodide indicate dead cells while cells stained green with fluorescent diacetate indicate live cells."

More Content

All (315) | News (190) | Reports (0) | Blogs (102) | Audio/Video (0) | Fact Sheets (1) | Press Releases (22)
sort by: Date | Relevance
NeoStem: Timing Is Everything [Published Seeking Alpha - 3 hours ago]
The European Medicines Agency grants the "orpha... [Published Vall d'Hebron - 6 hours ago]
Regenerative Medicine Market (Bone and Joint) (... [Published PR Newswire: General Business - Sep 17 2014]
United Therapeutics Points to Pluristem's PLX-P... [Published BioMedReports - Sep 17 2014]
Business leader appointed to review Cooperative... [Published Australian Government - Sep 17 2014]
World’s First for AMD Stem Cell Therapy [Published BioPortfolio - Sep 17 2014]
New method puts Anya’s leukemia in remission [Published Hamilton Spectator - Sep 16 2014]
Northwest Bio's Cell Therapy Named 'Promising I... [Published BioPortfolio - Sep 16 2014]
RepliCel's CEO Garners Recognition on Fox Busin... [Published HispanicBusiness.com - Sep 15 2014]
“K-to-M” histone mutations: how repressing the ... [Published Health Canal - Sep 15 2014]
The shadow of a disease [Published Health Canal - Sep 13 2014]
Clinical trials start for treating advanced sol... [Published Health Canal - Sep 13 2014]
Woman Receives First Stem Cell Therapy Using He... [Published Time - Sep 12 2014]
Woman Receives First Stem Cell Therapy Using He... [Published TIME.com - Sep 12 2014]
New Nanomedicine Provides Faster, More Efficien... [Published Crawford Financial Planning - Sep 12 2014]
Global Cirrhosis Therapeutics Pipeline Review 2... [Published Individual.com - Sep 12 2014]
Global Bone Marrow Transplantation Therapeutics... [Published Individual.com - Sep 12 2014]
Global Anaplastic Astrocytoma Therapeutics Pipe... [Published Individual.com - Sep 12 2014]
OVATION Hair® Surpasses 1 Million Order Milestone [Published PRWeb - Sep 12 2014]
Bahamas to become stem cell 'pacesetter' [Published The Tribune - Sep 11 2014]
Another Cell Therapy for MS Proves Safety [Published MedPageToday.com - medical news plus CME for ph ... - Sep 11 2014]
Posting Title: (viewable for applicants)Senior ... [Published PharmaDiversity - Sep 11 2014]
Global Venous Leg Ulcers (Crural ulcer) Therape... [Published Individual.com - Sep 11 2014]
Stem Cell Institute Public Seminar on Adult Ste... [Published Bio-Medicine - Sep 11 2014]
Stem Cell Institute Public Seminar on Adult Ste... [Published PRWeb - Sep 11 2014]
"Saccharide-Peptide Hydrogels" in Patent Applic... [Published 4 Traders - Sep 11 2014]
"Mutant Ctla4 Gene Transfected T Cell and Compo... [Published HispanicBusiness.com - Sep 10 2014]
Author Tory Williams Sets Out To Engage The Pub... [Published PR Newswire: Entertainment & Media - Sep 10 2014]
T-Cell Leukemia Therapeutics Pipeline Review 20... [Published Individual.com - Sep 10 2014]
Applying Targeting Mechanisms to Stem Cell Therapy [Published Longevity Meme - Sep 10 2014]
1 2 3 4 5 6 7 8 9 10 ...
In Focus
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
Content Volume
Document Volume
Network
Network

Blogs

sort by: Date | Relevance
Regenerative Medicine Market (Bone and Joint) (... [Published PR Newswire: General Business - Sep 17 2014]
LONDON, Sept. 17, 2014 /PRNewswire/ -- U.S. National Institute of Health stated that regenerative medicine is the process of creating functional tissue to repair and replace tissue or organ which has lost their function due to damage, congenital defects, ...
Woman Receives First Stem Cell Therapy Using He... [Published TIME.com - Sep 12 2014]
Researchers at the RIKEN Center for Developmental Biology in Japan surgically transplanted a sheet of retinal pigment cells into the eye of a 70-year old women on Friday. The cells are the first induced pluripotent stem cells, or iPS cells, given to ...
Another Cell Therapy for MS Proves Safety [Published MedPageToday.com - medical news plus CME for ph ... - Sep 11 2014]
BOSTON (MedPage Today) -- A closely watched phase I trial of autologous mesenchymal stem cells (MSCs) for multiple sclerosis proved that the treatment was safe, with some hints that it might have helped some patients on the efficacy side. ...
Author Tory Williams Sets Out To Engage The Pub... [Published PR Newswire: Entertainment & Media - Sep 10 2014]
NEW ROCHELLE, New York, Sept. 10, 2014 /PRNewswire/ -- Mary Ann Liebert, Inc., leading publisher of over 80 science, technology, and medical publications, announced today the launch of first time hard cover title Inevitable Collision: The Inspiring ...
Check Out Who You Can Meet at IBC’s Cell Therap... [Published Future of BioPharma - Sep 03 2014]
IBC's 4th Annual Cell Therapy Bioprocessing meeting is less than two weeks away, coming to the Sheraton Pentagon City in Arlington, VA on September 15-16, 2014.Join these confirmed attendees next month to gain the strategies and approaches you ...
1 2 3 4 5 6 7 8 9 10 ...

Press Releases

sort by: Date | Relevance
NeoStem and PCT, A NeoStem Company, to Present ... [Published GlobeNewswire: Advertising News - Sep 09 2014]
Cellular Biomedicine Group Launches Clinical Re... [Published GlobeNewswire: Acquisitions News - Sep 02 2014]
Yarmouth Veterinarian Provides Stem Cell Therap... [Published GlobeNewswire: Acquisitions News - Aug 31 2014]
Cesca Therapeutics Advocates Benefits of Cell T... [Published GlobeNewswire: Advertising News - Aug 27 2014]
ViaCyte, Inc. Raises $5.4 Million in a Private ... [Published Financial Services - Aug 08 2014]
1 2 3 4 5
Contact Us
Sales
Support


Freebase CC-BY Some image thumbnails are sourced from Freebase, licensed under CC-BY

Copyright (C) 2014 Silobreaker Ltd. All rights reserved.
The selection and placement of stories and images on any Silobreaker page are determined automatically by a computer program.
The time or date displayed reflects when an article was added to or updated in Silobreaker.